• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

The LSD Conference: A Molecular Masterclass – Call for Speakers

Microdose by Microdose
January 20, 2022
in Events
Reading Time: 3 mins read
A A
The LSD Conference: A Molecular Masterclass – Call for Speakers

Microdose Psychedelic Insights (“Microdose”), your guide to the business of psychedelics, in partnership with MindBio Therapeutics a clinical-stage drug development company conducting research into microdosing and medicinal use of psychedelic medicines to treat a range of debilitating mental health conditions are pleased to announce our upcoming LSD Conference and an open call for speakers.

The one-day virtual conference will take place on February 17th, starting at 1:30pm EST.

Are you an expert or thought leader, researcher, clinician, or advocate working with the LSD and looking to share your insights with the world? Apply now to take center stage at Microdose’s next Molecular Masterclass, The LSD Conference, a one-day virtual conference featuring international leaders who are impacting the psychedelic medicine industry.

Join us as we take a scientific deep dive into the dynamic field of LSD therapeutics, with expert panels and engaging discussions. We’ll explore the science, history, culture, medical benefits, and future of this crucial psychedelic compound.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

If you are interested in speaking at The LSD Conference, please apply by completing our online submission form.

Continue on your trip...

Wonderland 2023 Review: PsychMD

Microdose Announces Dr. Sam Clark, CEO of Terran Biosciences, as Wonderland 2023 Keynote Presenter

The World on Drugs: Documentary Premiere at Wonderland

The Molecular Masterclass is a speaker series designed for deep dives into the world’s favorite psychoactive and psychedelic substances. The upcoming LSD Masterclass will feature content on:

  • The History of That “Curious Molecule”
  • Therapeutic Use of LSD in Psychiatry
  • Posology and Tolerance to Regression
  • Safety and Efficacy of Lysergic Acid Diethylamide Assisted Psychotherapy
  • LSD Microdosing in Late-Stage Cancer Patients
  • Effect of Lysergic Acid Diethylamide (LSD) on Learning
  • The Effects of LSD on Creativity

If you feel that your expertise and experience positions you as a thought-leader in the space, we invite you to complete the application to become a speaker at this cutting-edge event.

If you are interested in speaking or learning about sponsorship opportunities for The LSD Conference, reach out to daniela@microdose.buzz for details or book a call

Direct Lasix Purchase

now.

Check out previous events: The Ketamine Conference, The Ibogaine Conference, The Mushroom Conference, and The MDMA Conference.

WHY BE A SPEAKER?

Microdose conferences are highly regarded by market leaders across the psychedelic medicine sector, thanks to our consistently strong and well-respected speakers and content. As a speaker at one of Microdose’s events, you will have the opportunity to give an expert presentation, and network with other key participants and new entrants in the field.

  • Be recognized as an industry expert and thought-leader
  • Complimentary all-access pass to the event
  • 2 complimentary tickets for your colleagues
  • Contribution toward moving the industry forward with new initiatives and ideas
  • 30% revenue share on ticket sales that come through your unique link
  • Receive visibility in pre-event, and post-event marketing materials, including social media, direct event promotion, email newsletters, and promotional partners.

GUIDELINES

  • To be considered for a speaking slot, complete the form. Speaker selections will be made by the selection team and notifications will go out to all those that are chosen to speak via email.
  • Please submit only thorough topic presentations and demonstration of expertise.
  • Presentations should last between 30-60 minutes overall (depending on the topic and structure of the session), including Q&A from the audience. You must be an expert on the subject and be able to converse fluently in an organic manner.
  • We are looking for a diverse lineup of speakers including both those who have spoken at psychedelic medicine events in the past and those who have not, speakers covering a diverse range of geographic areas, those who are at different stages of their company evolution, and speakers who have not spoken recently or ever at one of our conferences as we strive to increase diversity and inclusion in all of our event productions.
[bsa_pro_ad_space id=2]
ADVERTISEMENT
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Eleusis: New Psychedelic Player Coming to the NASDAQ

Eleusis: New Psychedelic Player Coming to the NASDAQ

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.